MIR548AX

Across TCGA pan-cancer cohorts, MIR548AX RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR548AX data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR548AX RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548AX expression acts as an unfavorable survival marker.

BRCA, ESCA, and LAML are the cancer types where MIR548AX RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	II,III,IV	0.726	0.892	.001	66	view →
ESCA	OS	Tertile	All	0.301	0.710	<.001	63	view →
LAML	DFS	Tertile	All	0.216	0.486	.016	18	view →
LIHC	OS	Tertile	All	0.140	0.783	.002	18	view →
STAD	DFS	Tertile	IV	0.141	0.444	.047	9	view →
LGG	DFS	Tertile	All	0.181	0.731	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR548AX–BRCA (DFS)

Open the BRCA breakdown →